149 related articles for article (PubMed ID: 8690304)
1. [Nephrotoxicity and drug interaction of vancomycin (2)].
Toyoguchi T; Nakagawa Y
Nihon Yakurigaku Zasshi; 1996 May; 107(5):225-35. PubMed ID: 8690304
[TBL] [Abstract][Full Text] [Related]
2. [Nephrotoxicity and drug interaction of vancomycin].
Toyoguchi T; Nakagawa Y; Watanabe H
Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):53-66. PubMed ID: 8721008
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits.
Toyoguchi T; Takahashi S; Hosoya J; Nakagawa Y; Watanabe H
Antimicrob Agents Chemother; 1997 Sep; 41(9):1985-90. PubMed ID: 9303398
[TBL] [Abstract][Full Text] [Related]
4. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
Hatano K; Yokota Y; Hanaki H; Sunakawa K
Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131
[TBL] [Abstract][Full Text] [Related]
5. [Modification of vancomycin nephrotoxicity by other antibiotics in rats].
Itoh F; Sato K; Harauchi T; Hirata M; Mizushima Y
Jpn J Antibiot; 1995 Mar; 48(3):380-8. PubMed ID: 7752451
[TBL] [Abstract][Full Text] [Related]
6. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
Nakamura T; Hashimoto Y; Kokuryo T; Inui KI
Pharm Res; 1998 May; 15(5):734-8. PubMed ID: 9619782
[TBL] [Abstract][Full Text] [Related]
7. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
[TBL] [Abstract][Full Text] [Related]
10. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. II. Results against gram-negative rods].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Nov; 46(11):946-52. PubMed ID: 8309070
[TBL] [Abstract][Full Text] [Related]
11. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
[TBL] [Abstract][Full Text] [Related]
12. [Effect of imipenem/cilastatin combined with vancomycin for MRSA infection].
Fukabori T; Mizobuchi K; Nakamura M; Takizawa H; Takashina R; Fujita Y
Jpn J Antibiot; 1997 Apr; 50(4):299-305. PubMed ID: 9192247
[TBL] [Abstract][Full Text] [Related]
13. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
Kouda M
Jpn J Antibiot; 1993 Feb; 46(2):142-53. PubMed ID: 8331774
[TBL] [Abstract][Full Text] [Related]
14. [In vitro synergism of two-drug combinations among cefamandole, flomoxef and imipenem against MRSA].
Inoue M; Sakurai N; Matsui H; Tsunoda M; Okubo T
Jpn J Antibiot; 1990 Feb; 43(2):233-8. PubMed ID: 2362351
[TBL] [Abstract][Full Text] [Related]
15. [The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
Higurashi Y; Okuzumi K; Yoneyama A; Nakahara K
Jpn J Antibiot; 1997 Dec; 50(12):907-16. PubMed ID: 9545668
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of imipenem/cilastatin sodium and fosfomycin as second-line combination chemotherapy in severe infections associated with hematologic disorders].
Tsuda S; Kuzuyama Y; Nakai H; Seriu T; Takashima T; Tanaka S; Horiike S; Taniwaki M; Misawa S; Kashima K
Jpn J Antibiot; 1993 Feb; 46(2):171-83. PubMed ID: 8331778
[TBL] [Abstract][Full Text] [Related]
17. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats.
Nishino Y; Takemura S; Minamiyama Y; Hirohashi K; Ogino T; Inoue M; Okada S; Kinoshita H
Free Radic Res; 2003 Apr; 37(4):373-9. PubMed ID: 12747731
[TBL] [Abstract][Full Text] [Related]
18. Time-Dependent Alterations of Vancomycin-Induced Nephrotoxicity in Mice.
Takigawa M; Masutomi H; Kishimoto Y; Shimazaki Y; Hamano Y; Kondo Y; Arai T; Lee J; Ishii T; Mori Y; Ishigami A
Biol Pharm Bull; 2017; 40(7):975-983. PubMed ID: 28674262
[TBL] [Abstract][Full Text] [Related]
19. [In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
Sato S; Miura T; Kudo E; Kudo Y; Saitoh Y; Kimpara I; Tsujino M; Kudo H
Jpn J Antibiot; 1997 Aug; 50(8):711-6. PubMed ID: 9339397
[TBL] [Abstract][Full Text] [Related]
20. Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats.
Konishi H; Morita Y; Mizumura M; Iga I; Nagai K
J Chemother; 2013 Oct; 25(5):273-8. PubMed ID: 24070134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
